Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion type Assertion NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_head.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion description "[Taken together, results obtained from in vitro studies indicate that therapeutic targeting of CXCR2 might aid in lowering A? levels in the AD brain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion evidence source_evidence_literature NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion SIO_000772 21084199 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion wasDerivedFrom befree-20140225 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.
- NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_assertion wasGeneratedBy ECO_0000203 NP718865.RA4prp66c02lhPiwIgZNSikB8eHou7BtHxi0Pca0nIoW8130_provenance.